!function(f,b,e,v,n,t,s) {if(f.fbq)return;n=f.fbq=function(){n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}; if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version='2.0'; n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0]; s.parentNode.insertBefore(t,s)}(window,document,'script', 'https://connect.facebook.net/en_US/fbevents.js'); fbq('init', '276673106762734'); fbq('track', 'PageView'); window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4GY0QXZ2C8'); window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'AW-313010535');

LifeOmic is working with leading healthcare institutions in oncology to identify effective treatments, targetable genomic markers and mutations, as well as guide patients to clinical trials using our cloud-based software. We’re also on a mission to use wellness as a tool to move healthcare upstream to prevention. Our platform allows subjects to harness patient data and lifestyle factors shown to help prevent cancer and reduce side effects from cancer treatment, including plant-based Nutrition, Exercise, Sleep, Mindfulness-based stress reduction and Intermittent Fasting with our free mobile app, LIFE Extend.

12-12:40 pm How Not to Die From Cancer | Michael Greger, M.D., FACLM

What happens when we put cancer on a plant-based diet? Hear the compelling results from Dr. Michael Greger, author of New York Times Best Seller “How Not to Die” and Founder of NutritionFacts.org. Dr. Greger will also join us for a live Q&A to answer your questions about cancer and nutrition.

But I’m So Tired! Why You Should Exercise Anyway | Kathryn Schmitz, PhD, MPH, FACSM

It’s a paradox, but that doesn’t make it less true. The very symptoms that make you feel that you cannot or should not exercise are often the ones made better by exercise. In this science based talk, Dr. Kathryn Schmitz will review that evidence, share the current exercise guidelines for those affected by cancer, and offer behavior change tips supported by scientific evidence.

Medical Trauma and PTSD: The Impact on Patients’ Emotional Health | Paul George, MS

Post traumatic stress disorder impairs our neurological functioning and therefore our emotional functioning; we can get triggered into feeling small, helpless, hopeless, and incompetent or defective. Mr. Paul discusses how he addresses medical trauma PTSD to mitigate the shame most of us experience when we are triggered into PTSD and wind up feeling some or all of these feelings and will cover strategies that can heal PTSD through EMDR (Eye Movement Desensitization and Processing). He also discusses the ways in which our current healthcare system, and many of its providers, both consciously and unconsciously diminish patients, including the use of electronic medical record keeping. How the medical system treats patients and how medical providers talk to patients can be shaming and diminishing to consumers in the system.

Navigating Cancer Treatments Using Precision Diagnostics for Oncology | Anthony Magliocco, MD

An overview of revolutionary diagnostic advances and their impact on cancer treatment. Coverage of recent advances in molecular pathology, genetics, liquid biopsy and multiplex tissue analysis.

More about the Speakers:

Jamie L. Renbarger, MD, MS is Professor, Department of Pediatrics, Division Chief of Pediatric Hematology/Oncology, Caroline Symmes Profesor in Pediatric Cancer Research, and Director of the Pediatric Cancer Precision Genomics Program, Riley Hospital for Children. Dr. Renbarger completed her medical school and residency training at St. Louis University, St. Louis, Missouri and her Fellowship at Baylor College of Medicine, Houston, Texas. Her clinical interests are in pediatric stem cell transplantation and clinical pharmacology of anti-neoplastic agents in children. Dr. Renbarger’s research interests are in personalized medicine and pharmacogenomics in the treatment of childhood cancers. Her work involves a major effort to identify biomarkers of drug toxicity and efficacy in the treatment of pediatric cancer. The ultimate goal is to use these biomarkers to develop simple, robust and practical/clinical predictors of response to medications in individual patients that can be used to optimize dosing in the treatment of children, many of whom have curable malignancies. Dr. Renbarger has a very strong interest in survivorship care for pediatric cancer patients and recently opened the Karuna Precision Wellness Center to help cancer survivors enhance their quality of life. Her research accomplishments were honored as a 2011 recipient of a Presidential Early Career Award for Scientists and Engineers (PECASE).

Don Brown, MD. Don is the most successful serial software entrepreneur in the Midwest. His first company was acquired by EDS in 1986. He founded Software Artistry in 1988 which became the first software company in Indiana ever to go public and was later acquired by IBM for $200 million. Don then founded and served as CEO of Interactive Intelligence which went public in 1999 and was acquired by Genesys Telecommunications Laboratories in 2016 for $1.4 billion. He is also an active technology and business advisor, investor, and philanthropist. In 2016, Don donated $30 million for the establishment of the Brown Immunotherapy Center at the Indiana University School of Medicine. Don received a bachelor’s in physics from Indiana University in 1978, a master’s in computer science from IU in 1982, an MD from the Indiana University School of Medicine in 1985, and a master’s in biotechnology from Johns Hopkins University in 2017.

A founding member and Fellow of the American College of Lifestyle Medicine, Michael Greger, MD, is a physician, New York Times bestselling author, and internationally recognized speaker on nutrition. He has videos on more than 2,000 health topics freely available at NutritionFacts.org, with new videos and articles uploaded almost every day. Dr. Greger has lectured at the Conference on World Affairs, testified before Congress, and was invited as an expert witness in the defense of Oprah Winfrey in the infamous “meat defamation” trial. He is a graduate of Cornell University School of Agriculture and Tufts University School of Medicine. Three of his recent books— How Not to Die, the How Not to Die Cookbook, and How Not to Diet all became instant New York Times Best Sellers. His latest two books, How to Survive a Pandemic and the How Not to Diet Cookbook, were released in 2020. All proceeds he receives from the sales of his books go to charity.

Kathryn Schmitz, PhD, MPH, FACSM, is a Distinguished Professor of Public Health Sciences at the Pennsylvania State University’s College of Medicine. She is a clinical trialist who has led many exercise trials. Dr. Schmitz also has translated her work into clinical practice and served as president of the American College of Sports Medicine (ACSM). Dr. Schmitz has chaired the Global Exercise Is Medicine Governing Committee, and she is the founder of the Moving Through Cancer Initiative of the ACSM. Dr. Schmitz has published more than 260 peer-reviewed scientific papers (h-index 62) and has had $25 million dollars in funding for her research since 2001. She was the lead author of the first ACSM Roundtable on Exercise for Cancer Survivors. In March 2018, Dr. Schmitz co-chaired an International Multidisciplinary ACSM Roundtable on Exercise and Cancer Prevention and Control. The physicians, outpatient rehabilitation specialists, researchers, and exercise professionals in the room broadly agreed it is time for exercise oncology to go prime time. The question is how. Dr. Schmitz’ professional mission is to answer that question.

Paul George, MS is a private psychotherapist specializing in the treatment of trauma. He is an EMDRIA Certified EMDR therapist and an EMDRIA Approved Consultant in EMDR. He learned much of what he knows and uses now in private practice from seventeen years of experience in Community Mental Health centers in Indianapolis. These were medical settings where he evaluated people in crisis coming to clinics but also did evaluation and brief treatment with patients in emergency rooms and on medical wards at two hospitals in Indianapolis. He also worked for ten years on an outpatient addictions team at one of these facilities. He has come to understand through the experience of his clients, medical patients and his own medical experience that there are a variety of ways that we can be traumatized, diminished and even shamed by medical institutions and medical providers, particularly when we are struggling with chronic pain, very serious and chronic health conditions. Though men are certainly victimized in this way, historically and currently women are more likely to receive medical treatment that is detrimental to their emotional well being at the very time when they are amid an ongoing medical crisis. It can be very helpful to understand better how medical treatment can be triggering and traumatizing as well as how we can be both implicitly and explicitly diminished as medical patients in the health care system. Understanding and support from family and friends about these issues, coaching from professionals about how to advocate for and protect yourself in medical settings and trauma resolution work with a therapist can all be helpful in our quests for health and wholeness.

Anthony Magliocco, MD is a board certified Pathologist and Professor of Oncology and Pathology with over 30 years of experience in tissue pathology, medical research, molecular diagnostics, liquid biopsy, genetics, digital image analysis and clinical trials. He has founded and led multiple clinical laboratories and has overseen the deployment of numerous new laboratory tests in his career in both Canada and the USA. He has published over 200 research articles, has numerous patents issued and applied, and is a frequent invited speaker to international diagnostic technology meetings. He was Chair of Pathology at the Moffitt Cancer Center, Scientific Director of the tissue core at Moffitt, and chair of Pathology in the national cooperative groups RTOG and NRG oncology. In his extensive peer-reviewed research he has developed new digital image analysis methods and has created numerous new diagnostic tests used to aid selection of treatment plans for patients with breast, ovary, lung, bladder and many other cancers. He founded fellowship programs in digital imaging and molecular diagnostics at the Moffitt Cancer Center. He founded the hereditary cancer program in Saskatchwan and was the pathology leader of numerous tumor groups at the Tom Baker Cancer Center in Canada. He also served as medical and scientific director of multiple regional and national tumor banks. His deep knowledge of molecular biology and medicine enable him to identify tests and tools that are unique in their ability to contribute to the future of medical diagnostics. His interest and aptitude for business enables him to create a viable pathway for implementation of these tests and tools. His vision is to move medical diagnostics forward to keep pace with scientific discoveries. Most recently he founded Protean BioDiagnostics and raised multiple rounds of funding. He has developed the unique Oncology MAPS system, currently the only comprehensive precision medicine system aimed at supporting community based cancer patients and their doctors. He is the PI of multiple ongoing biomarker based clinical trials.